HealthEquity Historical Income Statement

HQY Stock

USD 101.54 0.93 0.91%

Historical analysis of HealthEquity income statement accounts such as Selling General Administrative of 108.8 M or Selling And Marketing Expenses of 83.2 M can show how well HealthEquity performed in making a profits. Evaluating HealthEquity income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of HealthEquity's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining HealthEquity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether HealthEquity is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

About HealthEquity Income Statement Analysis

HealthEquity Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to HealthEquity shareholders. The income statement also shows HealthEquity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

HealthEquity Income Statement Chart

At this time, HealthEquity's EBITDA is fairly stable compared to the past year. Cost Of Revenue is likely to rise to about 395.8 M in 2024, despite the fact that Total Other Income Expense Net is likely to grow to (50.4 M).

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Ebit Research Development

Total Revenue

Total revenue comprises all receipts HealthEquity generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of HealthEquity minus its cost of goods sold. It is profit before HealthEquity operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from HealthEquity's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into HealthEquity current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.At this time, HealthEquity's EBITDA is fairly stable compared to the past year. Cost Of Revenue is likely to rise to about 395.8 M in 2024, despite the fact that Total Other Income Expense Net is likely to grow to (50.4 M).

	2021	2022	2023	2024 (projected)
Gross Profit	423.7M	490.1M	622.6M	653.8M
Total Revenue	756.6M	861.7M	999.6M	1.0B

Gross Profit Total Revenue

HealthEquity income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Reconciled Depreciation	Extraordinary Items	Net Interest Income	Interest Income	Non Recurring
Depreciation And Amortization		0.95	0.92	0.92	0.93	0.92	0.95	0.6	0.12	0.96	0.81	0.95	0.95	-0.17	-0.91	-0.2	-0.07	-0.21	0.87	-0.28	0.96	0.58	-0.99	0.07	0.95
Interest Expense	0.95		0.97	0.97	0.98	0.98	0.99	0.73	0.37	0.99	0.92	0.98	0.97	0.0	-0.98	-0.03	0.07	-0.04	0.7	-0.16	0.94	0.66	-0.95	0.21	0.91
Selling General Administrative	0.92	0.97		0.99	1.0	0.99	1.0	0.79	0.42	0.98	0.93	1.0	0.99	0.04	-0.96	0.03	0.05	0.02	0.66	-0.25	0.93	0.58	-0.92	0.12	0.89
Selling And Marketing Expenses	0.92	0.97	0.99		1.0	1.0	0.99	0.81	0.47	0.99	0.96	0.98	0.98	0.11	-0.97	0.1	0.12	0.08	0.65	-0.17	0.91	0.65	-0.93	0.23	0.88
Total Revenue	0.93	0.98	1.0	1.0		1.0	1.0	0.8	0.43	0.99	0.95	0.99	0.99	0.06	-0.97	0.05	0.09	0.04	0.67	-0.2	0.93	0.63	-0.93	0.18	0.9
Gross Profit	0.92	0.98	0.99	1.0	1.0		0.99	0.83	0.48	0.99	0.96	0.99	0.97	0.13	-0.97	0.11	0.15	0.1	0.66	-0.14	0.91	0.67	-0.92	0.24	0.88
Other Operating Expenses	0.95	0.99	1.0	0.99	1.0	0.99		0.75	0.36	0.99	0.92	1.0	0.99	-0.01	-0.97	-0.02	0.03	-0.03	0.71	-0.25	0.95	0.6	-0.95	0.13	0.92
Operating Income	0.6	0.73	0.79	0.81	0.8	0.83	0.75		0.82	0.75	0.93	0.75	0.7	0.63	-0.7	0.62	0.54	0.61	0.38	0.24	0.56	0.74	-0.62	0.53	0.61
Ebit	0.12	0.37	0.42	0.47	0.43	0.48	0.36	0.82		0.37	0.68	0.35	0.3	0.85	-0.37	0.84	0.72	0.84	-0.17	0.5	0.13	0.57	-0.17	0.66	0.13
Research Development	0.96	0.99	0.98	0.99	0.99	0.99	0.99	0.75	0.37		0.93	0.98	0.98	0.03	-0.97	0.0	0.09	-0.01	0.74	-0.17	0.94	0.67	-0.97	0.22	0.92
Ebitda	0.81	0.92	0.93	0.96	0.95	0.96	0.92	0.93	0.68	0.93		0.91	0.88	0.37	-0.9	0.35	0.37	0.34	0.55	0.09	0.79	0.76	-0.84	0.44	0.78
Cost Of Revenue	0.95	0.98	1.0	0.98	0.99	0.99	1.0	0.75	0.35	0.98	0.91		1.0	-0.03	-0.97	-0.04	0.0	-0.05	0.69	-0.29	0.95	0.56	-0.94	0.08	0.91
Total Operating Expenses	0.95	0.97	0.99	0.98	0.99	0.97	0.99	0.7	0.3	0.98	0.88	1.0		-0.09	-0.97	-0.1	-0.06	-0.11	0.7	-0.34	0.97	0.52	-0.95	0.03	0.91
Income Before Tax	-0.17	0.0	0.04	0.11	0.06	0.13	-0.01	0.63	0.85	0.03	0.37	-0.03	-0.09		0.06	0.98	0.87	0.99	-0.21	0.77	-0.24	0.51	0.11	0.78	-0.14
Total Other Income Expense Net	-0.91	-0.98	-0.96	-0.97	-0.97	-0.97	-0.97	-0.7	-0.37	-0.97	-0.9	-0.97	-0.97	0.06		0.08	-0.01	0.08	-0.61	0.23	-0.94	-0.61	0.91	-0.16	-0.88
Net Income	-0.2	-0.03	0.03	0.1	0.05	0.11	-0.02	0.62	0.84	0.0	0.35	-0.04	-0.1	0.98	0.08		0.77	1.0	-0.25	0.68	-0.25	0.45	0.14	0.71	-0.16
Income Tax Expense	-0.07	0.07	0.05	0.12	0.09	0.15	0.03	0.54	0.72	0.09	0.37	0.0	-0.06	0.87	-0.01	0.77		0.78	-0.05	0.88	-0.17	0.6	0.01	0.84	-0.05
Net Income From Continuing Ops	-0.21	-0.04	0.02	0.08	0.04	0.1	-0.03	0.61	0.84	-0.01	0.34	-0.05	-0.11	0.99	0.08	1.0	0.78		-0.26	0.69	-0.27	0.45	0.15	0.72	-0.17
Non Operating Income Net Other	0.87	0.7	0.66	0.65	0.67	0.66	0.71	0.38	-0.17	0.74	0.55	0.69	0.7	-0.21	-0.61	-0.25	-0.05	-0.26		-0.17	0.75	0.51	-0.85	0.05	0.84
Tax Provision	-0.28	-0.16	-0.25	-0.17	-0.2	-0.14	-0.25	0.24	0.5	-0.17	0.09	-0.29	-0.34	0.77	0.23	0.68	0.88	0.69	-0.17		-0.4	0.5	0.21	0.85	-0.26
Reconciled Depreciation	0.96	0.94	0.93	0.91	0.93	0.91	0.95	0.56	0.13	0.94	0.79	0.95	0.97	-0.24	-0.94	-0.25	-0.17	-0.27	0.75	-0.4		0.52	-0.95	-0.06	0.96
Extraordinary Items	0.58	0.66	0.58	0.65	0.63	0.67	0.6	0.74	0.57	0.67	0.76	0.56	0.52	0.51	-0.61	0.45	0.6	0.45	0.51	0.5	0.52		-0.6	0.78	0.65
Net Interest Income	-0.99	-0.95	-0.92	-0.93	-0.93	-0.92	-0.95	-0.62	-0.17	-0.97	-0.84	-0.94	-0.95	0.11	0.91	0.14	0.01	0.15	-0.85	0.21	-0.95	-0.6		-0.13	-0.93
Interest Income	0.07	0.21	0.12	0.23	0.18	0.24	0.13	0.53	0.66	0.22	0.44	0.08	0.03	0.78	-0.16	0.71	0.84	0.72	0.05	0.85	-0.06	0.78	-0.13		0.06
Non Recurring	0.95	0.91	0.89	0.88	0.9	0.88	0.92	0.61	0.13	0.92	0.78	0.91	0.91	-0.14	-0.88	-0.16	-0.05	-0.17	0.84	-0.26	0.96	0.65	-0.93	0.06

Click cells to compare fundamentals

HealthEquity Account Relationship Matchups

HealthEquity income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	206.3K	115.9M	137.2M	161.2M	153.1M	160.7M
Interest Expense	24.8M	34.9M	36.6M	48.4M	55.5M	58.2M
Selling General Administrative	60.6M	84.5M	84.4M	95.6M	103.7M	108.8M
Selling And Marketing Expenses	44.0M	50.0M	58.6M	68.8M	79.3M	83.2M
Total Revenue	532.0M	733.6M	756.6M	861.7M	999.6M	1.0B
Gross Profit	325.9M	415.3M	423.7M	490.1M	622.6M	653.8M
Other Operating Expenses	422.9M	653.6M	716.0M	824.1M	871.5M	915.0M
Operating Income	77.0M	83.3M	34.6M	38.9M	128.1M	134.5M
Ebit	155.2M	39.0M	(34.2M)	10.3M	129.3M	135.8M
Research Development	77.6M	124.8M	157.4M	193.4M	218.8M	229.8M
Ebitda	155.4M	154.9M	103.0M	171.5M	282.4M	296.5M
Cost Of Revenue	206.1M	318.2M	332.9M	371.7M	377.0M	395.8M
Total Operating Expenses	216.8M	335.3M	383.1M	452.4M	401.7M	421.8M
Income Before Tax	43.2M	4.1M	(66.7M)	(38.1M)	75.0M	78.8M
Total Other Income Expense Net	(33.9M)	(29.9M)	(42.5M)	(47.2M)	(53.1M)	(50.4M)
Net Income Applicable To Common Shares	39.7M	8.8M	(44.3M)	(26.1M)	(23.5M)	(22.4M)
Net Income	39.7M	8.8M	(44.3M)	(26.1M)	55.7M	58.5M
Income Tax Expense	3.5M	(4.7M)	(22.5M)	(12.0M)	19.3M	20.3M
Net Income From Continuing Ops	39.7M	8.8M	(44.3M)	(26.1M)	55.7M	58.5M
Non Operating Income Net Other	(2.2M)	(1.9M)	(9.1M)	5.0M	5.8M	6.0M
Tax Provision	3.5M	(4.7M)	(22.5M)	(12.0M)	19.3M	20.3M
Reconciled Depreciation	55.4M	115.9M	137.2M	161.2M	153.1M	103.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

HealthEquity Historical Income Statement

About HealthEquity Income Statement Analysis

HealthEquity Income Statement Chart

Total Revenue

Gross Profit

HealthEquity income statement Correlations

HealthEquity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

HealthEquity income statement Accounts

Also Currently Popular

Additional Tools for HealthEquity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 1.0	Selling General Administrative
Other Operating Expenses	+ 1.0	Selling General Administrative
Cost Of Revenue	+ 1.0	Selling General Administrative
Total Revenue	+ 1.0	Selling And Marketing Expenses
Gross Profit	+ 1.0	Selling And Marketing Expenses
Gross Profit	+ 1.0	Total Revenue

Net Interest Income	- 0.99	Depreciation And Amortization
Total Other Income Expense Net	- 0.98	Interest Expense
Total Other Income Expense Net	- 0.97	Total Operating Expenses
Total Other Income Expense Net	- 0.97	Cost Of Revenue
Net Interest Income	- 0.97	Research Development
Total Other Income Expense Net	- 0.97	Research Development